Testing policy
Since the 1980s, France's institutional framework of HIV testing has been based on wide access to free voluntary counselling and testing, routine testing in blood and tissue donors, and routinely offering HIV tests to pregnant women and to people getting married or entering prison. Since 1997, national and regional information campaigns have been launched to increase the awareness of the potential benefits of early diagnosis. However, these efforts remained mainly focused on people with high risk behaviours. The result of this policy is a high rate of testing, with 82 tests per 1000 population in 2004, the highest rate in Europe after 
Consequences of late diagnosis
Late diagnosis is associated with an increased risk of mortality. Sabin and colleagues found that one fifth of HIV related deaths occurred in patients who had discovered their infection within the six months before their death. [5] Chadborn and colleagues also reported late diagnosis was a risk factor for short term mortality (odds ratio=10.76, 95% confidence interval 7.68 to 15.91). [6] In France, mortality in the six months after detection of HIV infection was 16 times higher for patients diagnosed with advanced disease than for patients diagnosed earlier. [7] The mortality two years after a first positive test result was 9% among those with advanced infection compared with 1% among those with earlier detection, and the difference in mortality remained four years after diagnosis. Late diagnosis may also increase the costs of hospital care and management of opportunistic infections, especially immediately after diagnosis. A study by Krentz and colleagues in Canada found that the direct costs of management were twice as high for patients who had CD4 cell counts <20010 6 /l at HIV diagnosis than for those with a higher CD4 count. [16] Similarly, in France the total mean monthly cost for the management of patients without AIDS was €670 (£450; $900) per person when the CD4 cell count was >50010 6 /l compared with €1760 per person when the CD4 cell count was <5010 6 /l. [17] During the month after the onset of AIDS, the cost increased from €1760 to €4530 depending on the opportunistic infections. These results convey an increase in risk taking behaviours that is confirmed by rising numbers of sexually transmitted infections. Thus, the number of HIV infections could rise in the heterosexual population, and a substantial proportion of these future infections will be diagnosed late if testing policy does not change. France therefore needs urgently to improve testing policy to include the heterosexual population at low risk of infection but at high risk of late diagnosis.
Summary points
The rate of HIV testing in France is among the highest in Europe 
